decisionhealth Newsletters, Answer Books - 2009 Issue 1 (January)
Appendix A - Glossary / Supplies / Reimbursement for drugs and biologicals
Subscribe or sign in to view the full article.
Article Overview
This glossary-style appendix explains the broad Medicare coverage framework for drugs and biologicals. It is useful for physicians, coders, and billing staff who need a high-level understanding of reimbursement requirements, coverage limitations, and the general categories of guidance involved in determining whether a drug or biological may be paid by Medicare.
Why This Topic Matters
Drug and biological reimbursement depends on meeting multiple Medicare coverage criteria, so a clear overview helps readers understand the scope of payment rules before applying the full policy details.
What You Will Learn
- The general Medicare criteria used to evaluate reimbursement for drugs and biologicals
- How coverage concepts such as self-administration, immunization exclusions, and medical necessity are framed in the article
- The role of FDA approval and general incident-to service requirements in this reimbursement context
- The kinds of vaccine-related exceptions referenced in the overview
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Practice managers
- Compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com